Skip to main content

Find Clinical Trials

Home
Conditions
PALB2-Mutated Breast Carcinoma

Clinical trial condition

PALB2-Mutated Breast Carcinoma

Explore clinical trials studying PALB2-Mutated Breast Carcinoma. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

PALB2-Mutated Breast Carcinoma trial results

Recruiting

Phase Ib Study of Axatilimab in Combination With Olaparib in BRCA1/2 and PALB2- Associated Metastatic HER2-negative Breast Cancer

NCT06488378

Conditions: BRCA1 Mutation, BRCA2 Mutation, Breast Cancer, +8 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Brigham and Women's Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details